Printer Friendly

Analysis of metabolomic patterns in thoroughbreds before and after exercise.


Exercise affects metabolic responses throughout the body [']. During exercise, muscles generate ATP by using various intramuscular and extramuscular substrates such as creatine phosphate, muscle glycogen, blood-borne glucose, lactate, and free fatty acids. The various substrates for exercise metabolism are dependently determined by exercise intensity and duration as well as training status, dietary manipulation, and other environmental factors [2]. Exercise of maximal intensity increases the amount of lactate derived from the degradation of muscle glycogen, products of adenine nucleotide catabolism, and tricarboxylic acid cycle intermediates related to aerobic energy production [3]; it also promotes glycogenolysis, lipolysis, and ammonia metabolism [4]. Prolonged submaximal intensity exercise improves insulin sensitivity, arterial compliance, and endothelial function [5]; increases lipid catabolism [6]; decreases the catecholamine response [7]; and maintains bone density, skeletal muscle mass, and muscle metabolic capacity during ageing [8].

The equine skeletal muscle displays intrinsic metabolic adaptations based on myofiber structure and function, substrate and by-product transport across the sarcolemma, and coordinated integration of metabolic pathways to produce ATP in response to exercise [9]. Equine muscles store a large amount of glycogen (300 to 650 mol/g dry weight) in fast fibers. The stored glycogen is used as the most important source of energy for muscle contraction during both submaximal (<85% V[O.sub.2max]) and maximal exercise (>85% V[O.sub.2max]) [9]. During prolonged submaximal intensity exercise, lipids also contribute to produce muscle energy with glycogen [10]. After exercise, supplementation of muscle glycogen can slowly take up to 72 h in horses [11]. Previous studies have shown that muscle glycogen supplement after exercise was enhanced by certain processes such as intravenous glucose infusion, oral acetate administration, and rehydration with hypotonic electrolyte solutions in horses [12]. In addition, the buffering capacity that prevents muscle acidosis by lactate is higher in horses than in other species, probably because of high carnosine content [9]. Some studies have also suggested that equine adaptation to exercise could improve both aerobic and anaerobic capacities [9]. However, the mechanism underlying equine metabolism in response to exercise is still unclear.

Recently, multivariate approaches of metabolomic analysis have been used to understand biological mechanisms [13]. With respect to biological endpoints, quantifications of metabolomes could elucidate biological phenomena with other omics studies such as genomics, transcriptomics, and proteomics. For the acquisition of metabolic data, high-resolution [sup.1]H or [sup.13]C nuclear magnetic resonance (NMR) spectroscopy and mass spectroscopy have been used along with other spectroscopic methodologies [14,15]. The acquired data can be interpreted using multivariate statistical analysis, such as hierarchical cluster analysis, principal component analysis, different types of partial least square analysis, and subsequent modeling with new regression algorithms [16,17].

In this study, we analyzed the metabolic profiles of equine muscle, plasma, and urine before and after exercise by using [sup.1]H NMR spectroscopy. On the basis of the analysis results, commonly or specifically expressed metabolites were selected from the muscle, plasma, and urine, and they reflected the effects of exercise. Subsequently, we suggested metabolic pathways related to those metabolites. Our study could contribute to understanding fluctuations in equine metabolism because of exercise.


Horses and ethical statement

Three Thoroughbred were used in this study. The Pusan National University-Institutional Animal Care and Use Committee approved the study design (Approval Number: PNU-2015-0864).

Sample collection

Blood, muscle, and urine samples were collected from each horse before and after exercise (30 min). Briefly, venous blood samples were collected using a-50 mL syringe and transferred to heparin-containing tubes and centrifuged at 5,000 rpm for 15 min to obtain plasma. The plasma samples were stored at -20[degrees]C until NMR sample preparation. For skeletal muscle biopsy, local anesthesia was administered to the gluteus medius, and a biopsy collection syringe was used to obtain the muscle samples before and after exercise. The samples were stored in liquid nitrogen until analysis. Urine was collected from the subjects before and after exercise and centrifuged to remove solids. An 600 [micro]L aliquot of the supernatant was added to a micro centrifuge tube containing 70 [micro]L of D2O solution with 5 mM dextran sulphate sodium (DSS) and 10 mM imidazole. The DSS was used as the qualitative standard for the chemical shift scale. In addition, 30 [micro]L of 0.42% sodium azide was added. The urine samples were stored at -70[degrees]C until analysis.

Nuclear magnetic resonance spectroscopy

The skeletal muscle and plasma samples were subjected to [sup.1]H NMR spectroscopy analysis. Briefly, 45 [micro]L of the samples was used with 5 [micro]L of deuterium oxide ([D.sub.2]O) containing 20 mM of the reference material trimethylsilylpropionate (TSP); 20 mg of the skeletal muscle samples was analyzed with 25 [micro]L of D2O containing 2 mM of TSP, and 630 [micro]L of the urine samples was mixed with 70 [micro]L of D2O containing 20 mM of TSP before NMR measurement.

We conducted high-resolution magic angle spinning NMR for the skeletal muscle and plasma samples. The spinning rate was 2,050 Hz. To analyze the skeletal muscle, plasma, and urine samples, the Carr-Purcell-Meiboom-Gill pulse sequence was used to remove the water peak and macromolecular peak signal. The acquisition time was 1.704 s, and the relaxation delay was 1.0 s. Each sample was scanned 128 times, and the total analysis time was 8 min and 13 s.

Chenomx NMR Suite 7.1 (Chenomx Inc., Edmonton, AB, Canada) and SIMCAp+12.0 (Umetrics, Umea, Sweden) software were used to minimize the errors of the measured spectrum and statistical analysis, respectively. In this study, we quantified 22 metabolites in the plasma, while 33 metabolites were investigated in the skeletal muscle in both groups. We used TSP as the standard and measured the absolute concentrations of the metabolites to normalize the samples; the relative concentration of each metabolite was measured. The multivariate statistical analysis method was used to calculate the amount of metabolites present in the samples.

Orthogonal partial least square discriminant analysis

All data were converted from the NMR software format to the Microsoft Excel format. One-dimensional NMR spectra data were imported into SIMCA-P (version 12.0, Umetrics Inc., Kinnelon, NJ, USA) for multivariate statistical analysis, to examine intrinsic variations in the data set. These data were scaled using centered scaling prior to the orthogonal partial least square discriminant analysis (OPLS-DA). For the scaling process, the average value of each variable was calculated and then subtracted from the data. OPLS-DA score plots were used to interpret intrinsic variations in the data.

Statistical analysis

Means and standard deviations of the metabolites were calculated using Microsoft Excel. The statistical significance (p<0.05, p<0.01, or p<0.001) of apparent differences in metabolite concentrations before and after exercise was assessed using analysis of variance, followed by the f-test (Prism 5.01, San Diego, CA, USA).


Differentially expressed metabolites and metabolic patterns before and after exercise in horses

The metabolite analyses before and after exercise showed that 35, 25, and 34 metabolites were detected in the muscle, plasma, and urine, respectively. Sixteen metabolites were commonly changed among the muscle, plasma, and urine after exercise, and 11, 3, and 14 metabolites were specifically changed in the muscle, plasma, and urine, respectively, after exercise (Figure 1, Table 1). The relative levels of the metabolites after exercise in the muscle, plasma, and urine were measured and compared with the corresponding levels of before exercise. The results showed that aspartate, betaine, choline, cysteine, ethanol, and threonine were increased over 2-fold in the muscle; propionate and trimethylamine were increased over 2-fold in the plasma; and alanine, glycerol, inosine, lactate, and pyruvate were increased over 2-fold and acetoacetate, arginine, citrulline, creatine, glutamine, glutarate, hippurate, lysine, methionine, phenylacetylglycine, taurine, trigonelline, trimethylamine, and trimethylamine N-oxide were decreased below 0.5-fold in the urine (Figure 1).

OPLS-DA and variable important plots of the metabolites before and after exercise

OPLS-DA showed clear separation of the metabolic patterns before and after exercise in the muscle, plasma, and urine (Figure 2A, 2B, 2C). Subsequently, when variable important plots (VIPs) were derived from OPLS-DA for the metabolic patterns before and after exercise, the detected metabolites that contributed to separating the clusters in the respective samples were scored to reflect their priorities (Figure 2D, 2E, 2F). Lactate, creatine, taurine, and cysteine had VIP scores >1 in the muscle; lactate, alanine, glycine, trimethylamine, acetate, and choline had VIP scores >1 in the plasma; and lactate and glycerol had VIP scores >1 in the urine (Table 2).

Metabolites that responded to exercise When the levels of the differentially expressed (fold change >2 or <0.5) and high-VIP-score (VIP score >1) metabolites were collectively analyzed in the muscle, plasma, and urine, the expressed levels were observed to be significantly changed in the urine after exercise, while no significant differences were detected in the muscle and plasma before and after exercise. After exercise, acetoacetate, arginine, glutamine, hippurate, phenylacetylglycine trimethylamine, trimethylamine N-oxide, and trigonelline were significantly decreased by 38.8%, 44.6%, 19.6%, 22.7%, 33.8%, 30.6%, 37.8%, and 30.8%, respectively, while alanine, glycerol, inosine, lactate, and pyruvate were significantly increased by 436.7%, 2,184.4%, 1,008.8%, 8,347.9%, and 726.5%, respectively, in the urine (p<0.05; Figure 3). With respect to the commonly detected metabolites, alanine, glutamine, lactate, and pyruvate showed significantly different expressions in the urine after exercise (p<0.05; Figure 4); the concentrations of alanine, lactate, and pyruvate in the plasma were significantly higher than in the muscle and urine, whereas the concentration of glutamine was not signifycantly different between the muscle and plasma (p<0.05; Figure 4).

Enrichment analyses of metabolic pathways that responded to exercise

Enrichment analyses for the differentially expressed (fold change >2 or <0.5) and high-VIP-score (VIP score >1) metabolites were performed using MetaboAnalyst 3.0 [18], and 36 pathways were predicted (Table 3).


Metabolic alteration reflects biological responses to various genetic, transcriptiomic, proteomic, and environmental influences [19-21]. Many metabolic studies have applied to characterize metabolic patterns derived from altered gene function in plants [22,23], explore microbial metabolism [24], assess drug toxicity [25] and diagnostic applications [26], and discover biomarkers for animal health and disease [21,27,28]. Therefore, metabolic biomarkers are regarded as a promising tool for improving animal health and welfare.

Since domestication, horses have been selected for superior athletic traits related to strength, endurance, and speed. In particular, racehorses have undergone artificial structural and functional adaptations for athletic performances. As a result, racehorses developed maximal aerobic capacity, intramuscular energy stores, mitochondrial volume in the muscle, and oxygen-carrying capacity in the blood [29]. From the unique physiological properties, most of the metabolic studies on exercising horses focused on glycogen stores, whereas only a few studies have addressed muscle triglyceride or protein stores. During intensive short-term exercise, muscle glycogen stores may be depleted by 20% to 35%, and prolonged exercise results in a decline in muscle glycogen by 50% to 100% [30]. However after cessation of exercise, the rate of glycogen repletion is much lower in horses than in other animal species and human athletes [31]. In addition, exercise induces changes in the amino acid profile in the blood and muscle. An increase in branched-chain amino acids, such as leucine, isoleucine, and valine, has been observed during prolonged sub-maximal exercise in horses [32], and it may have been due to increased output by the liver in which proteolysis has been shown to accelerate during exercise [33]. Furthermore, certain amino acids are believed to be oxidized for energy production in the muscle [34], although the contribution of proteins to energy expenditure in horses during exercise is still unknown. Recently, exercise in young horses was associated with lipid metabolism, including choline and glycerol; carbohydrate metabolism, including lactate, fumarate, and glucose; and amino acid metabolism, including creatine, creatinine, phenylalanine, tyrosine, and glutamate [35]. Collectively, our results showed the consistency of the differentially expressed metabolites in relation with the enrichment analysis of the metabolic pathways. We also suggested additional metabolic changes during equine exercise.

Alanine, glutamine, lactate, and pyruvate, which were commonly detected among the muscle, plasma, and urine, showed significantly different expressions in the urine after exercise (p< 0.05). During exercise, muscle glycogen, which is a primary energy source, is sequentially processed to pyruvate and pyruvate and can be used to produce ATP aerobically or anaerobically through glycolysis [36]. When the muscle cannot use enough oxygen for aerobic glycolysis at high-exercise intensities, anaerobic glycolysis produces ATP in the cytosol of the muscle by the incomplete breakdown of glucose into lactate [36]. Subsequently, muscle lactate is excreted into the blood for the balance of production rate and removal [37]. Once in the bloodstream, lactate can be taken up by exercising or non-exercising skeletal muscles, kidney, or liver, where it is converted to pyruvate for gluconeogenesis [38]. Concurrently, when muscles degrade amino acids for energy needs, the resulting nitrogen is transaminated to pyruvate to produce alanine. This alanine is transported to the liver, where nitrogen enters the urea cycle and pyruvate is used to produce glucose [39]. In addition, glutamine is primarily synthesized from glutamate and glutamic acid in the skeletal muscle. Glutamine is considered important for the maintenance of the renal tubules, contributing to the healthy functioning of the kidneys. Glutamine in the kidneys contributes to the elimination of acids from the blood, and it is lysed to glutamate, aspartate, pyruvate, lactate, alanine, and citrate through a series of metabolic reactions [40]. Collectively, we suggest that the fluctuations in alanine, glutamine, lactate, and pyruvate are potentially associated with exercise in the muscle, blood, and urine of Thoroughbred horses (Figure 4). The balances of these metabolites in equine biofluid could be utilized as an effective indicator of feeding and management to maintain optimal racing performance.

In conclusion, we first tried to analyze the integrated metabolic patterns and enrichment of metabolic pathways in the muscle, plasma, and urine of racehorses before and after exercise. Our results could contribute to understanding metabolic regulation and development of metabolic markers for equine exercise.


We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.


This study was supported by grants from the Next Generation Bio Green 21 Program (No. PJ01117301, PJ01104401), Rural Development Administration, Republic of Korea.


[1.] Ball D. Metabolic and endocrine response to exercise: sympathoadrenal integration with skeletal muscle. J Endocrinol 2015;224:R79-95.

[2.] Hargreaves M. Skeletal muscle metabolism during exercise in humans. Clin Exp Pharmacol Physiol 2000;27:225-8.

[3.] Van Hall G, Jensen-Urstad M, Rosdahl H, et al. Leg and arm lactate and substrate kinetics during exercise. Am J Physiol Endocrinol Metab 2003;284:E193-205.

[4.] Lewis GD, Farrell L, Wood MJ, et al. Metabolic signatures of exercise in human plasma. Sci Transl Med 2010;2:33ra7.

[5.] Pierce GL, Donato AJ, LaRocca TJ, et al. Habitually exercising older men do not demonstrate age-associated vascular endothelial oxidative stress. Aging Cell 2011;10:1032-7.

[6.] Henderson GC, Alderman BL. Determinants of resting lipid oxidation in response to a prior bout of endurance exercise. J Appl Physiol 2014;116:95-103.

[7.] Kjaer M, Galbo H. Effect of physical training on the capacity to secrete epinephrine. J Appl Physiol 1988;64:11-6.

[8.] Olesen J, Gliemann L, Bienso R, et al. Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men. J Physiol 2014;592:1873-86.

[9.] Rivero JL, Hill EW Skeletal muscle adaptations and muscle genomics ofperformance horses. Vet J 2016;209:5-13.

[10.] Geor RJ, Hinchcliff KW, McCutcheon LJ, Sams RA. Epinephrine inhibits exogenous glucose utilization in exercising horses. J Appl Physiol 2000;88:1777-90.

[11.] Brojer J, Holm S, Jonasson R, Hedenstrom U, Essen-Gustavsson B. Synthesis of proglycogen and macroglycogen in skeletal muscle of standardbred trotters after intermittent exercise. Equine Vet J Suppl 2006;38:335-9.

[12.] Waller AP, Heigenhauser GJ, Geor RJ, Spriet LL, Lindinger MI. Fluid and electrolyte supplementation after prolonged moderate-intensity exercise enhances muscle glycogen resynthesis in Standardbred horses. J Appl Physiol 2009;106:91-100.

[13.] Jang HJ, Kim JW, Ryu SH, et al. Metabolic profiling of antioxidant supplement with phytochemicals using plasma [sup.1]H NMR-based metabolomics in humans. J Funct Foods 2016;24:112-21.

[14.] Barding GA, Jr., Salditos R, Larive CK. Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 2012;404:1165-79.

[15.] van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006;7:142.

[16.] Zang Q, Keire DA, Wood RD, et al. Class modeling analysis of heparin [sup.1]H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques. Anal Chem 2011;83: 1030-9.

[17.] Kim KB, Um SY, Chung MW, et al. Toxicometabolomics approach to urinary biomarkers for mercuric chloride (HgClJ-induced nephrotoxicity using proton nuclear magnetic resonance (;H NMR) in rats. Toxicol Appl Pharmacol 2010;249:114-26.

[18.] Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res 2015;43:W251-7.

[19.] German JB, Hammock BD, Watkins SM. Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 2005;1:3-9.

[20.] Oresic M, Vidal-Puig A, Hanninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn 2006;6:575-85.

[21.] Moore RE, Kirwan J, Doherty MK, Whitfield PD. Biomarker discovery in animal health and disease: the application of post-genomic technologies. Biomark Insights 2007;2:185-96.

[22.] Weckwerth W. Metabolomics in systems biology. Annu Rev Plant Biol 2003;54:669-89.

[23.] Schauer N, Fernie AR. Plant metabolomics: towards biological function and mechanism. Trends Plant Sci 2006;11:508-16.

[24.] Kell DB. Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol 2004;7:296-307.

[25.] Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153-61.

[26.] Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using [sup.1]H-NMR-based metabonomics. Nat Med 2002;8:1439-44.

[27.] Whitfield PD, Noble PJM, Major H, et al. Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 2005;1:215-25.

[28.] Dumas ME, Canlet C, Vercauteren J, Andre F, Paris A. Homeostatic signature of anabolic steroids in cattle using ;H-[sup.13]C HMBC NMR metabonomics. J Proteome Res 2005;4:1493-502.

[29.] Evans DL. Physiology of equine performance and associated tests of function. Equine Vet J 2007;39:373-83.

[30.] Hodgson DR, Rose RJ. The athletic horse. Principles and practice of equine sports medicine. Philadelphia, PA, USA: Saunders; 1994.

[31.] Vervuert I. Energy metabolism of the performance horse. In: Proceedings of the 5th European Equine Nutrition & Health Congress 2011; 2011 Apr 15-16: Waregem, Belgium: The Scientific Committee of the European Equine Health and Nutrition Congress; 2011.

[32.] Vervuert I, Coenen M, Watermulder E. Metabolic responses to oral tryptophan supplementation before exercise in horses. J Anim Physiol Anim Nutr (Berl) 2005;89:140-5.

[33.] Dohm GL, Tabscott EB, Kasperek GJ. Protein degradation during exercise and recovery. Med Sci Sports Exerc Suppl 1987;189:166-71.

[34.] Struder KH, Hollmann W, Platen P, et al. lterations in plasma free tryptophan and large neutral amino acids do not affect perceived exertion and prolactin during 90 min of treadmill exercise. Int J Sports Med 1996;17:73-9.

[35.] Luck MM, Le Moyec L, Barrey E, et al. Energetics of endurance exercise in young horses determined by nuclear magnetic resonance metabolomics. Front Physiol 2015;6:198.

[36.] Adeva-Andany M, Lopez-Ojen M, Funcasta-Calderon R, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion 2014;17:76-100.

[37.] Hubbard JL. The effect of exercise on lactate metabolism. J Physiol 1973;231:1-18.

[38.] Katz J, Tayek JA. Recycling of glucose and determination of the Cori Cycle and gluconeogenesis. Am J Physiol 1999;277:E401-7.

[39.] Shulman GI. Cellular mechanisms of insulin resistance in humans. Am J Cardiol 1999;84:3J-10J.

[40.] Leguina-Ruzzi A. Therapeutic targets of glutamine in parenteral nutrition: a medical science review. Int J Prev Treat 2015;4:34-9.

Hyun-Jun Jang (1,2), (a), Duk-Moon Kim (3), (a), Kyu-Bong Kim (1), Jeong-Woong Park (4), Jae-Young Choi (4), Jin Hyeog Oh (4), Ki-Duk Song (2), Suhkmann Kim (5) *, Byung-Wook Cho (4) *

* Corresponding Authors: Suhkmann Kim

Tel: +82-51-510-2240, Fax: +82-51-516-7421, E-mail:

Byung-Wook Cho

Tel: +82-55-350-5515, Fax: +82-55-350-5519, E-mail:

(1) College of Pharmacy, Dankook University, Cheonan 31116, Korea

(2) Department of Animal Biotechnology, Chonbuk National University, Jeonju 54896, Korea

(3) Department of Animal Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju 63243, Korea

(4) Department of Animal Science, College of Natural Resources and Life Sciences, Pusan National University, Miryang 50463, Korea

(5) Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Korea

(a) These authors contributed equally to this work.

Submitted Feb 3, 2017; Revised May 3, 2017; Accepted Jun 2, 2017

Caption: Figure 1. Metabolic clustering (left) and heatmap analysis of the differentially expressed metabolites (right) among the muscle, plasma, and urine.

Caption: Figure 2. Analysis of the metabolic patterns in equine muscle, plasma, and urine before and after exercise. Orthogonal partial least square discriminant analysis (OPLS-DA) (R2X: 0.977; R2Y: 0.852; [Q.sup.2]: -0.142) (A) and variable importance plots (VIPs) for the muscle (D). OPLS-DA (R2X: 0.889; R2Y: 0.883; [Q.sup.2]: -1.33) (B) and VIPs for the plasma (E). OPLS-DA (R2X: 0.987; R2Y: 1; [Q.sup.2]: 0.971) (C) and VIPs for the urine (F).

Caption: Figure 3. On the basis of the differentially expressed (fold change >2 or <0.5) or high-variable importance plots (VIPs)-score (VIP >1) metabolites, concentration of the metabolites in the urine before and after exercise. Error bars are expressed as standard deviation; * p<0.05; ** p<0.01; *** p<0.001.

Caption: Figure 4. The metabolic cycles for alanine, glutamine, lactate, and pyruvate from the muscle to the kidney, and the concentrations of alanine, glutamine, lactate, and pyruvate in the muscle, plasma, and urine before and after exercise.
Table 1. Metabolic clustering among the muscle, plasma, and urine

Clustering          Total   Metabolites

Muscle only         11      Anserine, aspartate, betaine, carnitine,
                            cysteine, ethanol, fumarate,
                            o-phosphocholine, o-phosphoethanolamine,
                            serine, sn-glyce- ro-3-phosphocholine
Plasma only         3       Formate, histidine, propionate
Urine only          13      Acetoacetate, allantoin, benzoate,
                            citrate, citrulline, glutarate,
                            hippurate, homocitrulline, inosine,
                            methylsuccinate, phenylac- etylglycine,
                            trigonelline, trimethylamine n-oxide
Muscle and plasma   5       Choline, glycine, myo-inositol,
                            phenylalanine, proline
Plasma and urine    1       Trimethylamine
Urine and muscle    3       Arginine, glucose, glycerol
Muscle, plasma,     16      Lactate, creatine, taurine, glutamine,
and urine                   methionine, threonine, pyruvate,
                            succinate, leucine, valine, isoleucine,
                            glutamate, alanine, acetate, tyrosine,

Table 2. VIP scores show the list of metabolites that contributed to
the separation of the clustering in the muscle ([R.sup.2]X: 0.977;
[R.sup.2]Y: 0.852; [Q.sup.2]: -0.142), plasma ([R.sup.2]X: 0.889;
[R.sup.2]Y: 0.883; [Q.sup.2]: -1.33), and urine ([R.sup.2]X: 0.987;
[R.sup.2]Y: 1; [Q.sup.2]: 0.971) before and after exercise

Var ID (Primary)      VIP         VIPcvSE

Lactate               4.33964     4.90219
Creatine              2.86407     3.73581
Taurine               1.15696     0.677321
Cysteine              1.07798     1.11629
Proline               0.950802    1.58483
O-                    0.768788    1.08083
Glutamine             0.757915    0.408429
Glucose               0.712887    5.76654
Choline               0.655007    0.984574
Carnitine             0.597443    1.45509
Betaine               0.560761    0.476186
Methionine            0.509355    0.76717
Threonine             0.490596    0.624621
Ethanol               0.489648    0.81646
Pyruvate              0.421163    1.43033
Succinate             0.419546    1.43253
Arginine              0.40325     0.711309
Leucine               0.340958    2.08214
Serine                0.339834    0.873955
Valine                0.274741    1.8082
Fumarate              0.221147    0.15998

Isoleucine            0.19769     1.37773
Glutamate             0.151078    1.67088
Anserine              0.147928    1.74206
Phenylalanine         0.147539    0.487178
O-Phosphocholine      0.129257    1.55877
Glycerol              0.117228    0.76393
myo-Inositol          0.113193    0.541967
Alanine               0.0848435   1.37882
sn-Glycero-3-         0.0792956   0.543817
Glycine               0.0652003   1.38621
Aspartate             0.0604699   1.36912
Acetate               0.0461708   0.938492
Tyrosine              0.032664    0.755125
Lysine                0.0203432   0.702034

Var ID           VIP         VIPcvSE

Lactate          3.75706     1.41472
Alanine          1.60664     1.205
Glycine          1.08877     1.57026
Trimethylamine   1.08766     1.87254
Acetate          1.05611     2.35361
Choline          1.05136     1.17688

Valine           0.927083    0.844553
Formate          0.788366    1.50607
Isoleucine       0.590047    0.434523
Pyruvate         0.588535    3.40277
Succinate        0.54452     1.40882
Tyrosine         0.485224    0.149815
Methionine       0.442662    0.236588
Glutamate        0.423751    0.939892
Propionate       0.422877    0.92142
Leucine          0.320238    0.485677
Proline          0.289082    0.731382
Phenylalanine    0.272284    0.387797
Taurine          0.235986    0.816538
Creatine         0.225572    0.492157
Lysine           0.217242    0.344466

myo-Inositol     0.151193    0.41876
Glutamine        0.109232    0.445521
Threonine        0.0471337   0.192853
Histidine        0.0349163   0.347014

Var ID (Primary)      VIP           VIPcvSE

Lactate               4.95072       0.185054
Glycerol              2.43861       0.961256
Hippurate             0.830247      0.844768
Benzoate              0.733784      0.860513
Pyruvate              0.64467       0.1 10574
Phenylacetylglycine   0.553367      0.73167

Alanine               0.483287      0.0354834
Glutamine             0.330252      0.337596
Acetate               0.225269      0.12487
Inosine               0.2025        0.0420699
Threonine             0.185985      0.128163
Taurine               0.133553      0.276668
Citrate               0.121972      0.0814875
Citrulline            0.1 17822     0.128122
Glutamate             0.1 12898     0.216093
Creatine              0.103247      0.271346
Methylsuccinate       0.101376      0.134033
Arginine              0.0948408     0.16968
Acetoacetate          0.0927904     0.284629
Trigonelline          0.0869787     0.0891645
Trimethylamine        0.0845139     0.127546
Glucose               0.0585096     0.144095
Methionine            0.0564183     0.0567537
Trimethylamine        0.0424139     0.0581431
Isoleucine            0.0411947     0.0560735
Lysine                0.0279116     0.11095
Glutarate             0.0243009     0.0617341
Tyrosine              0.0228266     0.0955172
Valine                0.01 15851    0.0491691
Succinate             0.01 13337    0.0459536

Leucine               0.0106587     0.073076
Homocitrulline        0.00670114    0.133487
Allantoin             0.000348166   0.206484

VIP, variable important plots; VIPcvSE, variables associated with
lower standard errors in relation to VIP

Bold box indicates major metabolites that have a VIP score of more
than 1 according to orthogonal partial least square discriminant

Table 3. List of metabolic pathways obtained using enrichment analysis
for the differentially expressed (fold change >2 or <0.5) and
high-VIP-score (VIP score >1) metabolites

Related metabolic pathway   Total   Expected   Hits   Raw p

Protein biosynthesis        19      0.622      5      0.000217
Urea cycle                  20      0.655      5      0.000283
Glycine, serine and         26      0.851      5      0.00105
threonine metabolism
Ammonia recycling           18      0.589      4      0.00204
Arginine and proline        26      0.851      4      0.00832
Pyruvate metabolism         20      0.655      3      0.0246
Betaine metabolism          10      0.327      2      0.0395
Methionine metabolism       24      0.785      3      0.04
Aspartate metabolism        12      0.393      2      0.0556
Biotin metabolism           4       0.131      1      0.125
Alanine metabolism          6       0.196      1      0.181
Taurine and hypotaurine     7       0.229      1      0.208
Gluconeogenesis             27      0.884      2      0.22
Cysteine metabolism         8       0.262      1      0.235
Malate-aspartate shuttle    8       0.262      1      0.235
Butyrate metabolism         9       0.295      1      0.26
Glutathione metabolism      10      0.327      1      0.284
Ketone body metabolism      10      0.327      1      0.284
Glucose-alanine cycle       12      0.393      1      0.331
Beta-alanine metabolism     13      0.425      1      0.353
Phenylalanine and           13      0.425      1      0.353
tyrosine metabolism
Lysine degradation          13      0.425      1      0.353
Glycerolipid metabolism     13      0.425      1      0.353
Purine metabolism           45      1.47       2      0.44
Propanoate metabolism       18      0.589      1      0.454
Glutamate metabolism        18      0.589      1      0.454
Phospholipid biosynthesis   19      0.622      1      0.472
Insulin signalling          19      0.622      1      0.472
Bile acid biosynthesis      49      1.6        2      0.485
Glycolysis                  21      0.687      1      0.507
Porphyrin metabolism        22      0.72       1      0.524
Citric acid cycle           23      0.753      1      0.54
Galactose metabolism        25      0.818      1      0.57
Valine, leucine and         36      1.18       1      0.706
isoleucine degradation
Pyrimidine metabolism       36      1.18       1      0.706
Tyrosine metabolism         38      1.24       1      0.726

Related metabolic pathway   Holm p   FDR

Protein biosynthesis        0.0174   0.0113
Urea cycle                  0.0224   0.0113
Glycine, serine and         0.0817   0.0279
threonine metabolism
Ammonia recycling           0.157    0.0408
Arginine and proline        0.632    0.133
Pyruvate metabolism         1        0.328
Betaine metabolism          1        0.4
Methionine metabolism       1        0.4
Aspartate metabolism        1        0.495
Biotin metabolism           1        0.999
Alanine metabolism          1        1
Taurine and hypotaurine     1        1
Gluconeogenesis             1        1
Cysteine metabolism         1        1
Malate-aspartate shuttle    1        1
Butyrate metabolism         1        1
Glutathione metabolism      1        1
Ketone body metabolism      1        1
Glucose-alanine cycle       1        1
Beta-alanine metabolism     1        1
Phenylalanine and           1        1
tyrosine metabolism
Lysine degradation          1        1
Glycerolipid metabolism     1        1
Purine metabolism           1        1
Propanoate metabolism       1        1
Glutamate metabolism        1        1
Phospholipid biosynthesis   1        1
Insulin signalling          1        1
Bile acid biosynthesis      1        1
Glycolysis                  1        1
Porphyrin metabolism        1        1
Citric acid cycle           1        1
Galactose metabolism        1        1
Valine, leucine and         1        1
isoleucine degradation
Pyrimidine metabolism       1        1
Tyrosine metabolism         1        1

Raw p, raw p value; FDR, false discovery rate.
COPYRIGHT 2017 Asian - Australasian Association of Animal Production Societies
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Jang, Hyun-Jun; Kim, Duk-Moon; Kim, Kyu-Bong; Park, Jeong-Woong; Choi, Jae-Young; Hyeog Oh, Jin; Son
Publication:Asian - Australasian Journal of Animal Sciences
Article Type:Report
Date:Nov 1, 2017
Previous Article:Effects of a traditional Chinese medicine formula and its extraction on muscle fiber characteristics in finishing pigs, porcine cell proliferation...
Next Article:Comparative analysis of the microbial communities in raw milk produced in different regions of Korea.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters